2022-2027 Global and Regional Low Molecular Weight Heparin Industry Status and Prospects Professional Market Research Report Standard Version
Date: Jan-2022 | Id: MACRC-74156 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Low Molecular Weight Heparin market was valued at 25.64 Million USD in 2021 and will grow with a CAGR of 5.4% from 2021 to 2027, based on Mnemonics Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da. In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second`s largest market with the share of 30.49%. At present, the major manufacturers of Low Molecular Weight Heparin are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc. Aspen, Sanofi-aventis and Pfizer are industry-leading manufacturers of top-quality Low Molecular Weight Heparins. China is a big low molecular weight heparin production country, especially Heparin API, but it is not strong country. According to our research and analysis, manufacturers from United States and Europe are the major leaders in the international market of low molecular weight heparin. Manufacturers from China are immature in technology. There is large space in the China market, as well as big gap between international brands and local brands on price. In application, low molecular weight heparin downstream is wide and recently low molecular weight heparin has acquired increasing significance in various fields of treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter and others. Globally, the low molecular weight heparin market is mainly driven by growing demand for treatment of venous thromboembolism which accounts for nearly 65.24% of total downstream consumption of low molecular weight heparin in global. By Market Verdors: Aspen Sanofi-aventis Pfizer Opocrin CSBIO Dongying Tiandong Pharmaceutical Changzhou Qianhong Bio-pharma Techdow Yantai Dongcheng Pharmaceutical Group By Types: Enoxaparin Dalteparin Tinzaparin Fraxiparine By Applications: Treatment of Venous Thromboembolism Complications of Pregnancy Cardioversion of Atrial Fibrillation/Flutter Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview 1.1 Definition 1.2 Assumptions 1.3 Research Scope 1.4 Market Analysis by Regions 1.4.1 North America Market States and Outlook (2022-2027) 1.4.2 East Asia Market States and Outlook (2022-2027) 1.4.3 Europe Market States and Outlook (2022-2027) 1.4.4 South Asia Market States and Outlook (2022-2027) 1.4.5 Southeast Asia Market States and Outlook (2022-2027) 1.4.6 Middle East Market States and Outlook (2022-2027) 1.4.7 Africa Market States and Outlook (2022-2027) 1.4.8 Oceania Market States and Outlook (2022-2027) 1.4.9 South America Market States and Outlook (2022-2027) 1.5 Global Low Molecular Weight Heparin Market Size Analysis from 2022 to 2027 1.5.1 Global Low Molecular Weight Heparin Market Size Analysis from 2022 to 2027 by Consumption Volume 1.5.2 Global Low Molecular Weight Heparin Market Size Analysis from 2022 to 2027 by Value 1.5.3 Global Low Molecular Weight Heparin Price Trends Analysis from 2022 to 2027 1.6 COVID-19 Outbreak: Low Molecular Weight Heparin Industry Impact Chapter 2 Global Low Molecular Weight Heparin Competition by Types, Applications, and Top Regions and Countries 2.1 Global Low Molecular Weight Heparin (Volume and Value) by Type 2.1.1 Global Low Molecular Weight Heparin Consumption and Market Share by Type (2016-2021) 2.1.2 Global Low Molecular Weight Heparin Revenue and Market Share by Type (2016-2021) 2.2 Global Low Molecular Weight Heparin (Volume and Value) by Application 2.2.1 Global Low Molecular Weight Heparin Consumption and Market Share by Application (2016-2021) 2.2.2 Global Low Molecular Weight Heparin Revenue and Market Share by Application (2016-2021) 2.3 Global Low Molecular Weight Heparin (Volume and Value) by Regions 2.3.1 Global Low Molecular Weight Heparin Consumption and Market Share by Regions (2016-2021) 2.3.2 Global Low Molecular Weight Heparin Revenue and Market Share by Regions (2016-2021) Chapter 3 Production Market Analysis 3.1 Global Production Market Analysis 3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 3.1.2 2016-2021 Major Manufacturers Performance and Market Share 3.2 Regional Production Market Analysis 3.2.1 2016-2021 Regional Market Performance and Market Share 3.2.2 North America Market 3.2.3 East Asia Market 3.2.4 Europe Market 3.2.5 South Asia Market 3.2.6 Southeast Asia Market 3.2.7 Middle East Market 3.2.8 Africa Market 3.2.9 Oceania Market 3.2.10 South America Market 3.2.11 Rest of the World Market Chapter 4 Global Low Molecular Weight Heparin Sales, Consumption, Export, Import by Regions (2016-2021) 4.1 Global Low Molecular Weight Heparin Consumption by Regions (2016-2021) 4.2 North America Low Molecular Weight Heparin Sales, Consumption, Export, Import (2016-2021) 4.3 East Asia Low Molecular Weight Heparin Sales, Consumption, Export, Import (2016-2021) 4.4 Europe Low Molecular Weight Heparin Sales, Consumption, Export, Import (2016-2021) 4.5 South Asia Low Molecular Weight Heparin Sales, Consumption, Export, Import (2016-2021) 4.6 Southeast Asia Low Molecular Weight Heparin Sales, Consumption, Export, Import (2016-2021) 4.7 Middle East Low Molecular Weight Heparin Sales, Consumption, Export, Import (2016-2021) 4.8 Africa Low Molecular Weight Heparin Sales, Consumption, Export, Import (2016-2021) 4.9 Oceania Low Molecular Weight Heparin Sales, Consumption, Export, Import (2016-2021) 4.10 South America Low Molecular Weight Heparin Sales, Consumption, Export, Import (2016-2021) Chapter 5 North America Low Molecular Weight Heparin Market Analysis 5.1 North America Low Molecular Weight Heparin Consumption and Value Analysis 5.1.1 North America Low Molecular Weight Heparin Market Under COVID-19 5.2 North America Low Molecular Weight Heparin Consumption Volume by Types 5.3 North America Low Molecular Weight Heparin Consumption Structure by Application 5.4 North America Low Molecular Weight Heparin Consumption by Top Countries 5.4.1 United States Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 5.4.2 Canada Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 5.4.3 Mexico Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 Chapter 6 East Asia Low Molecular Weight Heparin Market Analysis 6.1 East Asia Low Molecular Weight Heparin Consumption and Value Analysis 6.1.1 East Asia Low Molecular Weight Heparin Market Under COVID-19 6.2 East Asia Low Molecular Weight Heparin Consumption Volume by Types 6.3 East Asia Low Molecular Weight Heparin Consumption Structure by Application 6.4 East Asia Low Molecular Weight Heparin Consumption by Top Countries 6.4.1 China Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 6.4.2 Japan Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 6.4.3 South Korea Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 Chapter 7 Europe Low Molecular Weight Heparin Market Analysis 7.1 Europe Low Molecular Weight Heparin Consumption and Value Analysis 7.1.1 Europe Low Molecular Weight Heparin Market Under COVID-19 7.2 Europe Low Molecular Weight Heparin Consumption Volume by Types 7.3 Europe Low Molecular Weight Heparin Consumption Structure by Application 7.4 Europe Low Molecular Weight Heparin Consumption by Top Countries 7.4.1 Germany Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 7.4.2 UK Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 7.4.3 France Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 7.4.4 Italy Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 7.4.5 Russia Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 7.4.6 Spain Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 7.4.7 Netherlands Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 7.4.8 Switzerland Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 7.4.9 Poland Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 Chapter 8 South Asia Low Molecular Weight Heparin Market Analysis 8.1 South Asia Low Molecular Weight Heparin Consumption and Value Analysis 8.1.1 South Asia Low Molecular Weight Heparin Market Under COVID-19 8.2 South Asia Low Molecular Weight Heparin Consumption Volume by Types 8.3 South Asia Low Molecular Weight Heparin Consumption Structure by Application 8.4 South Asia Low Molecular Weight Heparin Consumption by Top Countries 8.4.1 India Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 8.4.2 Pakistan Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 8.4.3 Bangladesh Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 Chapter 9 Southeast Asia Low Molecular Weight Heparin Market Analysis 9.1 Southeast Asia Low Molecular Weight Heparin Consumption and Value Analysis 9.1.1 Southeast Asia Low Molecular Weight Heparin Market Under COVID-19 9.2 Southeast Asia Low Molecular Weight Heparin Consumption Volume by Types 9.3 Southeast Asia Low Molecular Weight Heparin Consumption Structure by Application 9.4 Southeast Asia Low Molecular Weight Heparin Consumption by Top Countries 9.4.1 Indonesia Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 9.4.2 Thailand Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 9.4.3 Singapore Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 9.4.4 Malaysia Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 9.4.5 Philippines Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 9.4.6 Vietnam Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 9.4.7 Myanmar Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 Chapter 10 Middle East Low Molecular Weight Heparin Market Analysis 10.1 Middle East Low Molecular Weight Heparin Consumption and Value Analysis 10.1.1 Middle East Low Molecular Weight Heparin Market Under COVID-19 10.2 Middle East Low Molecular Weight Heparin Consumption Volume by Types 10.3 Middle East Low Molecular Weight Heparin Consumption Structure by Application 10.4 Middle East Low Molecular Weight Heparin Consumption by Top Countries 10.4.1 Turkey Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 10.4.2 Saudi Arabia Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 10.4.3 Iran Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 10.4.4 United Arab Emirates Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 10.4.5 Israel Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 10.4.6 Iraq Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 10.4.7 Qatar Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 10.4.8 Kuwait Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 10.4.9 Oman Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 Chapter 11 Africa Low Molecular Weight Heparin Market Analysis 11.1 Africa Low Molecular Weight Heparin Consumption and Value Analysis 11.1.1 Africa Low Molecular Weight Heparin Market Under COVID-19 11.2 Africa Low Molecular Weight Heparin Consumption Volume by Types 11.3 Africa Low Molecular Weight Heparin Consumption Structure by Application 11.4 Africa Low Molecular Weight Heparin Consumption by Top Countries 11.4.1 Nigeria Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 11.4.2 South Africa Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 11.4.3 Egypt Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 11.4.4 Algeria Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 11.4.5 Morocco Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 Chapter 12 Oceania Low Molecular Weight Heparin Market Analysis 12.1 Oceania Low Molecular Weight Heparin Consumption and Value Analysis 12.2 Oceania Low Molecular Weight Heparin Consumption Volume by Types 12.3 Oceania Low Molecular Weight Heparin Consumption Structure by Application 12.4 Oceania Low Molecular Weight Heparin Consumption by Top Countries 12.4.1 Australia Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 12.4.2 New Zealand Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 Chapter 13 South America Low Molecular Weight Heparin Market Analysis 13.1 South America Low Molecular Weight Heparin Consumption and Value Analysis 13.1.1 South America Low Molecular Weight Heparin Market Under COVID-19 13.2 South America Low Molecular Weight Heparin Consumption Volume by Types 13.3 South America Low Molecular Weight Heparin Consumption Structure by Application 13.4 South America Low Molecular Weight Heparin Consumption Volume by Major Countries 13.4.1 Brazil Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 13.4.2 Argentina Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 13.4.3 Columbia Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 13.4.4 Chile Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 13.4.5 Venezuela Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 13.4.6 Peru Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 13.4.7 Puerto Rico Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 13.4.8 Ecuador Low Molecular Weight Heparin Consumption Volume from 2016 to 2021 Chapter 14 Company Profiles and Key Figures in Low Molecular Weight Heparin Business 14.1 Aspen 14.1.1 Aspen Company Profile 14.1.2 Aspen Low Molecular Weight Heparin Product Specification 14.1.3 Aspen Low Molecular Weight Heparin Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.2 Sanofi-aventis 14.2.1 Sanofi-aventis Company Profile 14.2.2 Sanofi-aventis Low Molecular Weight Heparin Product Specification 14.2.3 Sanofi-aventis Low Molecular Weight Heparin Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.3 Pfizer 14.3.1 Pfizer Company Profile 14.3.2 Pfizer Low Molecular Weight Heparin Product Specification 14.3.3 Pfizer Low Molecular Weight Heparin Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.4 Opocrin 14.4.1 Opocrin Company Profile 14.4.2 Opocrin Low Molecular Weight Heparin Product Specification 14.4.3 Opocrin Low Molecular Weight Heparin Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.5 CSBIO 14.5.1 CSBIO Company Profile 14.5.2 CSBIO Low Molecular Weight Heparin Product Specification 14.5.3 CSBIO Low Molecular Weight Heparin Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.6 Dongying Tiandong Pharmaceutical 14.6.1 Dongying Tiandong Pharmaceutical Company Profile 14.6.2 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Product Specification 14.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.7 Changzhou Qianhong Bio-pharma 14.7.1 Changzhou Qianhong Bio-pharma Company Profile 14.7.2 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Product Specification 14.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.8 Techdow 14.8.1 Techdow Company Profile 14.8.2 Techdow Low Molecular Weight Heparin Product Specification 14.8.3 Techdow Low Molecular Weight Heparin Production Capacity, Revenue, Price and Gross Margin (2016-2021) 14.9 Yantai Dongcheng Pharmaceutical Group 14.9.1 Yantai Dongcheng Pharmaceutical Group Company Profile 14.9.2 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Product Specification 14.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Production Capacity, Revenue, Price and Gross Margin (2016-2021) Chapter 15 Global Low Molecular Weight Heparin Market Forecast (2022-2027) 15.1 Global Low Molecular Weight Heparin Consumption Volume, Revenue and Price Forecast (2022-2027) 15.1.1 Global Low Molecular Weight Heparin Consumption Volume and Growth Rate Forecast (2022-2027) 15.1.2 Global Low Molecular Weight Heparin Value and Growth Rate Forecast (2022-2027) 15.2 Global Low Molecular Weight Heparin Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027) 15.2.1 Global Low Molecular Weight Heparin Consumption Volume and Growth Rate Forecast by Regions (2022-2027) 15.2.2 Global Low Molecular Weight Heparin Value and Growth Rate Forecast by Regions (2022-2027) 15.2.3 North America Low Molecular Weight Heparin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.4 East Asia Low Molecular Weight Heparin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.5 Europe Low Molecular Weight Heparin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.6 South Asia Low Molecular Weight Heparin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.7 Southeast Asia Low Molecular Weight Heparin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.8 Middle East Low Molecular Weight Heparin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.9 Africa Low Molecular Weight Heparin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.10 Oceania Low Molecular Weight Heparin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.2.11 South America Low Molecular Weight Heparin Consumption Volume, Revenue and Growth Rate Forecast (2022-2027) 15.3 Global Low Molecular Weight Heparin Consumption Volume, Revenue and Price Forecast by Type (2022-2027) 15.3.1 Global Low Molecular Weight Heparin Consumption Forecast by Type (2022-2027) 15.3.2 Global Low Molecular Weight Heparin Revenue Forecast by Type (2022-2027) 15.3.3 Global Low Molecular Weight Heparin Price Forecast by Type (2022-2027) 15.4 Global Low Molecular Weight Heparin Consumption Volume Forecast by Application (2022-2027) 15.5 Low Molecular Weight Heparin Market Forecast Under COVID-19 Chapter 16 Conclusions Research Methodology